New York's medical community has been at the forefront of longevity and functional medicine in the United States, and NAD+ therapy is no exception. From Manhattan's concierge medicine practices and Brooklyn's functional health clinics to Long Island's medical spas and Westchester's integrative medicine offices, New York providers are offering NAD+ subcutaneous injections as part of comprehensive anti-aging and metabolic health programs.

If you're a licensed New York provider looking to add or expand NAD+ therapy, this guide covers the supply standards, regulatory landscape, and how to get your clinic set up with a compliant supply partner.

NAD+ therapy has gained significant traction in New York's sophisticated medical market for several reasons:

Patient Demand — New York's health-conscious patient population, particularly in Manhattan and Brooklyn, has high awareness of NAD+ and its potential benefits for energy, cognition, and longevity. Patients are actively seeking providers who offer NAD+ therapy.

Operational Efficiency — Subcutaneous NAD+ injections are far more operationally efficient than IV infusions. New York practices with limited space and high patient volume find subcutaneous protocols much more scalable.

Revenue Diversification — NAD+ therapy is a high-value service that complements GLP-1 programs, hormone optimization, and peptide protocols, allowing New York practices to offer comprehensive longevity medicine programs.

New York's regulatory environment demands rigorous documentation from compounding suppliers. Providers should verify:

USA cGMP Manufacturing — NAD+ for injection must be manufactured in a cGMP-compliant, FDA-registered USA facility. MedClinic Partners supplies NAD+ exclusively from USA-based cGMP manufacturers.

USP <797> Sterile Compounding — Injectable NAD+ must be compounded under USP <797> sterile conditions. New York providers should request and retain current compliance documentation from their supplier.

Certificate of Analysis — Every lot should include a third-party CoA confirming identity, potency, sterility, and endotoxin levels. New York's Office of the Professions expects thorough documentation for compounded medication use.

Lot Traceability — Full lot traceability from raw material to finished product is essential for New York practices subject to DOH inspections or audits.

Prescribing Requirements — NAD+ subcutaneous injections require a valid prescription from a licensed New York provider. New York requires a valid patient-provider relationship and thorough patient documentation for compounded medication prescribing.

New York DOH Compliance — New York practices subject to DOH oversight should ensure their NAD+ protocols align with DOH standards for medication storage, administration, and patient documentation.

Storage Requirements — Compounded NAD+ injectables require refrigeration at 2–8°C. New York practices must maintain compliant medication storage logs.

Telehealth Prescribing — New York permits telehealth prescribing of compounded medications, including NAD+, provided the prescriber holds an active New York license and meets New York's telehealth documentation requirements.

Manhattan Concierge Medicine — Manhattan's concierge medicine practices are among the most sophisticated NAD+ users in the country. These practices typically offer NAD+ as part of comprehensive longevity programs combining GLP-1s, peptides, hormone optimization, and advanced diagnostics.

Brooklyn and Queens Functional Medicine — Brooklyn and Queens' growing functional medicine community has embraced NAD+ for energy, cognitive performance, and metabolic health.

GLP-1 + NAD+ Combination — New York clinics are increasingly pairing NAD+ with compounded semaglutide or tirzepatide. The combination supports mitochondrial function and energy metabolism, which benefits patients experiencing fatigue during GLP-1 titration.

Executive Health Programs — New York's executive health and corporate wellness market represents a significant opportunity for NAD+ therapy, with demand for cognitive performance, energy optimization, and stress resilience.

We supply USA cGMP NAD+ subcutaneous injections to licensed medical practices throughout New York — Manhattan, Brooklyn, Queens, the Bronx, Staten Island, Long Island, Westchester, and upstate New York.

Same-Day Portal Access — New York providers can apply and receive portal access within 24 hours of NPI verification. NAD+ is available through the same portal as our GLP-1 and peptide products.

Overnight Delivery — All orders ship overnight in temperature-controlled packaging. New York City deliveries typically arrive before noon the following business day.

Compliance Documentation — Full CoA documentation and lot traceability are available through the portal for every order.

Apply online and receive portal access within 24 hours. Submit your NPI, New York license information, and practice details. Verification typically completes within hours, and you'll have access to our full product catalog — NAD+, compounded GLP-1s, and USA cGMP RUO peptides — with transparent wholesale pricing.